Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : NGLFINEBSE : 524774ISIN CODE : INE887E01022Industry : Pharmaceuticals & DrugsHouse : Private

BSE1442.0568.65 (+5 %)

PREV CLOSE ( ) 1373.40

OPEN PRICE ( ) 1419.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 2768

TODAY'S LOW / HIGH ( )1381.00 1442.05

52 WK LOW / HIGH ( )962.7 2774.4

NSE1435.9068.3 (+4.99 %)

PREV CLOSE( ) 1367.60

OPEN PRICE ( ) 1415.00

BID PRICE (QTY) 1435.90 (2082)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 4104

TODAY'S LOW / HIGH( ) 1404.30 1435.90

52 WK LOW / HIGH ( )957 2777.95

Chairman	Dhananjay Mungale
Managing Director	Rahul J Nachane
Company Secretary	Pallavi Pednekar
Non Executive Director	Ajita Nachane
Non Executive Independent Director	Jayaram Sitaram Milind V Shinde Sarala Menon
Whole Time Director	Rajesh N Lawande

Incorporation Year : 1981

Registered Office :

Address : 301 E Square,Subhash Road,Vile Parle (East) Mumbai,
Maharashtra-400057 .

Phone : 022 40842222

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE